Based on recent data, Avadel Pharmaceuticals plc (AVDL) shows an Average True Range (ATR) of 0.09 and an Enterprise Value of 1.6B. Its average trading volume over the past 3 months is 1.9M, indicating liquidity. These fundamental metrics provide insight into AVDL's underlying financial health and market activity.
| ATR | 0.09 |
| Enterprise Value | 1.6B |
| Avg Vol (3 Months) | 1.9M |
| Avg Vol (10 Days) | 1.75M |
Avadel Pharmaceuticals plc (AVDL) technical indicators as of February 11, 2026: the SMA 20 is 0.37%, SMA 50 at 0.63%, and SMA 200 at 40.81%. The RSI 14 value is 60.81, suggesting its current momentum. These technical analysis signals help assess AVDL's price trends and potential future movements.
| SMA 20 | 0.37% |
| SMA 50 | 0.63% |
| SMA 200 | 40.81% |
| RSI 14 | 60.81 |
Avadel Pharmaceuticals plc (AVDL) stock performance overview as of February 11, 2026: The 52-week high is $23.57 (currently -8.23% below), and the 52-week low is $6.38 (currently 239.03% above). Over the past year, AVDL's performance is 168.75%, compared to the S&P 500's 8.87% change.
| 52-Week High | 23.57 |
| 52-Week High Chg | -8.23% |
| 52-Week Low | 6.38 |
| 52-Week Low Chg | +239.03% |
| S&P 500 52-Week Chg | 8.87% |
According to market data, Avadel Pharmaceuticals plc (AVDL) stock's recent performance metrics show that over the last month, AVDL is 0.47%, with a Year-to-Date (YTD) performance of -0.23%. Over the past year, the stock has seen a 168.75% change. These figures summarize AVDL's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 21.71 | 21.71 | 23.57 | 23.57 | 23.57 | 21.71 |
| Low | 21.57 | 21.45 | 18.68 | 12.48 | 6.38 | 21.4 |
| Performance | 0 | +0.47% | +41.26% | +95.81% | +168.75% | -0.23% |
According to current financial data, AVDL stock's P/E (TTM) ratio is -7563.98, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for AVDL, including P/S (8.52), P/B (21.41), and P/FCF (59.83), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AVDL | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -7563.98 | -1.23 | 13.14 | 32.59 |
| P/S (TTM) | 8.52 | 3.71 | 6.11 | 5.98 |
| P/B (TTM) | 21.41 | 0.5 | 22.43 | 5.42 |
| P/FCF (TTM) | 59.83 | -15.24 | -2.53 | 31.77 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep